期刊文献+

Reproductive Challenges in Young Female Cancer Patients

Reproductive Challenges in Young Female Cancer Patients
原文传递
导出
摘要 The last three decades have seen a significant improvement and advancement in both the diagnostic and therapeutic modalities with improved surgical technique, chemoradio and supportive therapy in cancer treatment. This has produced a correspondingly increase in the 5-year relative survival rate for many cancers and for all races. However, the chemo-radiotherapy which is often gonadotoxic, has a substantial impact on quality of life issues especially that of reproduction in young female patients on account of increasing survival rates and delayed childbearing in the western hemisphere. This case based discussion paper using two real life case scenarios from our department focuses on the negative impact of cancer treatments on fertility and various options available for fertility preservation and / or fertility preservation measures. It is concluded that a lot of variables have to be considered when deciding upon fertility preservation treatments including patient's age, cancer stage, proposed treatment regime and time before it is initiated, availability of partner sperm and issues of individual patients. The latter include surgical complications, ovarian hyperstimu-lation syndrome, delay in cancer treatment and reintroduction of cancer cells, cost, low success rates and experimental nature of these treatments and the disposition of gametes in the event that the patient does not survive her cancer. It is very important for physician to advise patients of all these factors so that they can make an informed decision regarding the fertility preservation options and each case is unique and requires a different strategy of fertility preservation. The last three decades have seen a significant improvement and advancement in both the diagnostic and therapeutic modalities with improved surgical technique, chemoradio and supportive therapy in cancer treatment. This has produced a correspondingly increase in the 5-year relative survival rate for many cancers and for all races. However, the chemo-radiotherapy which is often gonadotoxic, has a substantial impact on quality of life issues especially that of reproduction in young female patients on account of increasing survival rates and delayed childbearing in the western hemisphere. This case based discussion paper using two real life case scenarios from our department focuses on the negative impact of cancer treatments on fertility and various options available for fertility preservation and / or fertility preservation measures. It is concluded that a lot of variables have to be considered when deciding upon fertility preservation treatments including patient's age, cancer stage, proposed treatment regime and time before it is initiated, availability of partner sperm and issues of individual patients. The latter include surgical complications, ovarian hyperstimu-lation syndrome, delay in cancer treatment and reintroduction of cancer cells, cost, low success rates and experimental nature of these treatments and the disposition of gametes in the event that the patient does not survive her cancer. It is very important for physician to advise patients of all these factors so that they can make an informed decision regarding the fertility preservation options and each case is unique and requires a different strategy of fertility preservation.
出处 《Journal of Reproduction and Contraception》 CAS 2014年第4期241-257,共17页 生殖与避孕(英文版)
关键词 fertility preservation chemotherapy RADIOTHERAPY in vitro fertilization (IVF) CRYOPRESERVATION cancer treatment in young females fertility preservation chemotherapy radiotherapy in vitro fertilization (IVF) cryopreservation cancer treatment in young females
  • 相关文献

参考文献62

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009. CA Cancer J Clin, 2009, 59(4):225-49.
  • 2Cervical cancer key facts. Cancer research UK 2012: Available from: http://www.cancerresearchuk.org/ cancer-info/cancerstats/keyfacts/cervical-cancer/.
  • 3Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod, 2001, 7(6):535-43.
  • 4Noyes N, Reh A, Mullin C, et al. Quality-of-life (QOL) assessment at time of fertility preservation (FP) counseling in female fertility patients: results of a university-based registry at two years. J Clin Oncol, 2010, 28(Supp15):e1964.
  • 5Duncan FE, Jozefik JK, Kim AM, et al. The gynecologist has a unique role in providing oncofertility care to young cancer patients. US Obstet Gynecol, 2011, 6(1):24-34.
  • 6Syse A, Kravdal O, Tretli S. Parenthood after cancer: a population-based study. Psychooncology, 2007, 16 (10):920-7.
  • 7Maltaris T, Seufert R, Fischl F, et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol, 2007, 130(2):148-55.
  • 8Averette HE, Boike GM, Jarrell MA. Effects of cancer chemotherapy on gonadal function and reproductive capacity. CA Cancer J Clin, 1990, 40(4):199-209.
  • 9Anderson RA, Cameron DA. Pretreatment serum anti-miillerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab, 2011, 96(5): 1336-43.
  • 10Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve. Fertil Steril, 2012, 98(6): 1407-15.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部